Our Institute is involved in the EUCanScreen project, where one of the key areas of focus is building synergies — that is, close collaboration with other EU-funded projects to strengthen the effectiveness of cancer screening campaigns and the development of the healthcare system in Europe.
Why does this matter?
- Exchanging knowledge, methods, resources, and experience between screening initiatives strengthens the impact of individual programs.
- Joint actions help avoid duplication of effort and create integrated solutions that work at every level — national and European.
Specific areas of EUCanScreen collaboration (WP10 and WP11):
- WP10 – Modeling and Health Technology Assessment (HTA): Developing and refining screening models, which makes it possible to analyze effectiveness, costs, and health impact across different countries and scenarios.
- WP11 – Capacity-Building: Conducting educational activities: leadership training, physician certification, colonoscopy audits, training in upper gastrointestinal endoscopy, and screening for cervical, breast, and lung cancer (low-dose CT).
Why is this important?
- By developing professional competencies across different countries, we improve the quality of screening.
- HTA models make it possible to optimize resources, assess the cost of procedures, and plan for the financial sustainability of screening programs.
- Collaboration with other initiatives helps spread practices and standards that work across different countries, including our own.
As EUCanScreen partners, we:
- actively participate in training initiatives (WP11),
- share our experience in conducting practical sessions and training,
- are involved in strategic planning discussions (HTA and modeling).
This is also a wonderful opportunity to demonstrate that Ukraine is not merely a recipient, but an active participant in European progress in cancer screening.
